| Literature DB >> 26195261 |
Agnes P Chan1, Granger Sutton1, Jessica DePew1, Radha Krishnakumar1, Yongwook Choi1, Xiao-Zhe Huang2, Erin Beck1, Derek M Harkins1, Maria Kim1, Emil P Lesho3, Mikeljon P Nikolich2, Derrick E Fouts4.
Abstract
BACKGROUND: Infections by pan-drug resistant Acinetobacter baumannii plague military and civilian healthcare systems. Previous A. baumannii pan-genomic studies used modest sample sizes of low diversity and comparisons to a single reference genome, limiting our understanding of gene order and content. A consensus representation of multiple genomes will provide a better framework for comparison. A large-scale comparative study will identify genomic determinants associated with their diversity and adaptation as a successful pathogen.Entities:
Mesh:
Year: 2015 PMID: 26195261 PMCID: PMC4507327 DOI: 10.1186/s13059-015-0701-6
Source DB: PubMed Journal: Genome Biol ISSN: 1474-7596 Impact factor: 13.583
Select genomic features and metadata of A. baumannii genomes sequenced in this study
| Number | Strain | Accession | G+C % | Finishing status† | Number of contigs | Number of proteins | Length (bp) | MLST ST | MLST allelic profile§ | Origin/site | Country | City | Year | Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1) | OIFC137 | AFDK00000000 | 36.9 | IHQD | 4 | 3871 | 4,081,420 | 3 | 3-3-2-2-3-1-3 | Catheter tip | USA | Washington, DC | 2003 | |
| 2) | OIFC032 | AFCZ00000000 | 40.8 | IHQD | 4 | 3718 | 3,893,886 | 32 | 1-1-2-2-3-4-4 | Wound | Germany | Landstuhl | 2003 | [ |
| 3) | OIFC109 | ALAL00000000 | 38.4 | IHQD | 13 | 3945 | 4,107,121 | 3 | 3-3-2-2-3-1-3 | Right residual limb wound | USA | Washington, DC | 2003 | [ |
| 4) | OIFC143 | AFDL00000000 | 37.3 | IHQD | 8 | 4265 | 4,441,327 | 25 | 3-3-2-4-7-2-4 | Thigh wound | USA | Washington, DC | 2003 | |
| 5) | OIFC189 | AFDM00000000 | 44.1 | IHQD | 10 | 3849 | 4,043,115 | 2 | 2-2-2-2-2-2-2 | Wound | USA | Bethesda, MD | 2003 | [ |
| 6) | Canada BC-5 | AFDN00000000 | 38.0 | IHQD | 3 | 3787 | 3,998,016 | 1 | 1-1-1-1-5-1-1 | Clinical isolate | Canada* | NA | 2007 | |
| 7) | Naval-17 | AFDO00000000 | 42.9 | IHQD | 21 | 3848 | 4,009,964 | 2 | 2-2-2-2-2-2-2 | Wound | USA | Bethesda, MD | 2006 | [ |
| 8) | Naval-18 | AFDA00000000 | 37.6 | IHQD | 11 | 4406 | 4,454,613 | 25 | 3-3-2-4-7-2-4 | Wound | USA | Bethesda, MD | 2006 | [ |
| 9) | Naval-81 | AFDB00000000 | 36.5 | IHQD | 5 | 3981 | 4,080,872 | 3 | 3-3-2-2-3-1-3 | Blood | USA | Bethesda, MD | 2006 | |
| 10) | IS-123 | ALII00000000 | 38.7 | IHQD | 20 | 4013 | 4,063,081 | 3 | 3-3-2-2-3-1-3 | Wound | Iraq | Baghdad | 2009 | |
| 11) | OIFC074 | AMDE00000000 | 40.5 | HQD | 66 | 3815 | 3,935,888 | 19 | 1-2-1-1-5-1-1 | Clinical isolate | Germany | Landstuhl | 2003 | |
| 12) | OIFC098 | AMDF00000000 | 39.5 | HQD | 72 | 3659 | 3,812,112 | 10 | 1-3-2-1-4-4-4 | Clinical isolate | Germany | Landstuhl | 2003 | |
| 13) | OIFC180 | AMDQ00000000 | 40.1 | HQD | 141 | 3942 | 3,986,823 | 2 | 2-2-2-2-2-2-2 | Clinical isolate | USA | NA | 2003 | |
| 14) | Naval-13 | AMDR00000000 | 40.6 | HQD | 64 | 3948 | 4,107,737 | 3 | 3-3-2-2-3-1-3 | Wound | USA | Bethesda, MD | 2006 | [ |
| 15) | IS-235 | AMEI00000000 | 41.0 | HQD | 76 | 3981 | 4,060,387 | 1 | 1-1-1-1-5-1-1 | Blood | Iraq | Baghdad | 2008 | [ |
| 16) | IS-251 | AMEJ00000000 | 39.6 | HQD | 72 | 3908 | 4,007,286 | 1 | 1-1-1-1-5-1-1 | Respiratory tract | Iraq | Baghdad | 2008 | [ |
| 17) | OIFC0162 | AMFH00000000 | 39.4 | HQD | 55 | 3856 | 4,078,399 | 412 | 1-52-2-2-67-4-5 | Trachea | USA | Washington, DC | 2003 | [ |
| 18) | Naval-72 | AMFI00000000 | 41.2 | HQD | 52 | 3607 | 3,840,453 | 405 | 5-3-16-4-29-1-60 | Wound | USA | Bethesda, MD | 2006 | [ |
| 19) | Naval-83 | AMFK00000000 | 39.7 | HQD | 103 | 4000 | 4,106,603 | 20 | 3-1-1-1-5-1-1 | Wound | USA | Bethesda, MD | 2006 | [ |
| 20) | OIFC110 | AMFL00000000 | 40.3 | HQD | 53 | 3818 | 3,981,666 | 515 | 56-3-2-2-9-4-14 | Clinical isolate | Germany | Landstuhl | 2003 | |
| 21) | IS-143 | AMGE00000000 | 41.1 | HQD | 93 | 3883 | 4,020,019 | 414 | 2-2-2-2-2-37-2 | Wound | Iraq | Baghdad | 2008 | |
| 22) | IS-116 | AMGF00000000 | 40.0 | HQD | 40 | 3779 | 3,952,511 | 136 | 3-2-19-25-5-2-5 | Wound | Iraq | Baghdad | 2008 | |
| 23) | WC-692 | AMGG00000000 | 39.7 | HQD | 79 | 4004 | 4,183,446 | 513 | 56-3-55-2-9-4-14 | Intact skin surface | Iraq | NA | 2008 | |
| 24) | IS-58 | AMGH00000000 | 40.9 | HQD | 61 | 3944 | 4,063,888 | 1 | 1-1-1-1-5-1-1 | Respiratory tract | Iraq | Baghdad | 2008 | [ |
| 25) | WC-487 | AMZR00000000 | 39.5 | HQD | 121 | 3994 | 4,115,076 | 410 | 20-26-26-14-26-16-23 | Skin | USA | Bethesda, MD | 2008 | |
| 26) | WC-348 | AMZT00000000 | 39.2 | HQD | 61 | 3897 | 4,108,488 | 412 | 1-52-2-2-67-4-5 | Intact skin surface | Iraq | NA | 2008 | |
| 27) | Naval-113 | AMZU01000000 | 49.7 | HQD | 130 | 4002 | 4,095,626 | 2 | 2-2-2-2-2-2-2 | Wound | USA | Bethesda, MD | 2006 | [ |
| 28) | Naval-82 | AMSW00000000 | 38.2 | HQD | 197 | 3969 | 3,908,929 | 428 | 3-1-2-3-6-1-16 | Blood | USA | Bethesda, MD | 2006 | [ |
| 29) | Naval-2 | AMSX00000000 | 39.5 | HQD | 114 | 4074 | 4,126,550 | 2 | 2-2-2-2-2-2-2 | Blood | USA | Bethesda, MD | 2006 | [ |
| 30) | Naval-21 | AMSY00000000 | 40.0 | HQD | 75 | 3829 | 3,923,796 | 19 | 1-2-1-1-5-1-1 | Wound | USA | Washington, DC | 2006 | [ |
| 31) | Canada BC1 | AMSZ00000000 | 39.7 | HQD | 66 | 3825 | 3,936,404 | 1 | 1-1-1-1-5-1-1 | Nosocomial infection | Canada | NA | 2007 | |
| 32) | WC-A-694 | AMTA00000000 | 39.7 | HQD | 82 | 3830 | 4,008,103 | 3 | 3-3-2-2-3-1-3 | Clinical isolate | USA | Washington, DC | 2008 | |
| 33) | OIFC035 | AMTB00000000 | 43.0 | HQD | 44 | 3741 | 3,972,611 | 403 | 3-2-6-1-3-4-59 | Groin wound | USA | Washington, DC | 2003 | |
| 34) | Naval-57 | AMFP00000000 | 40.7 | HQD | 138 | 3838 | 3,953,596 | 155 | 3-2-2-2-44-4-4 | Wound | USA | Bethesda, MD | 2006 | |
| 35) | OIFC087 | AMFS00000000 | 39.1 | HQD | 96 | 3922 | 4,004,682 | 32 | 1-1-2-2-3-4-4 | Perineum | USA | Washington, DC | 2003 | |
| 36) | OIFC099 | AMFT00000000 | 40.1 | HQD | 75 | 3748 | 3,918,177 | 32 | 1-1-2-2-3-4-4 | Environmental sample | USA | Washington, DC | 2003 | [ |
| 37) | WC-A-92 | AMFU00000000 | 38.1 | HQD | 151 | 3802 | 3,838,812 | 431 | 1-4-2-1-70-1-2 | Clinical isolate | USA | Washington, DC | 2007 | |
| 38) | OIFC065 | AMFV00000000 | 39.5 | HQD | 54 | 3893 | 4,029,646 | 136 | 3-2-19-25-5-2-5 | Left leg | USA | Washington, DC | 2003 | |
| 39) | OIFC047 | AMFW00000000 | 39.2 | HQD | 39 | 3505 | 3,740,684 | Novel | 1-75-2-2-67-1-2 | Perineum | USA | Washington, DC | 2003 | |
| 40) | OIFC338 | AMFX00000000 | 40.1 | HQD | 108 | 4081 | 4,155,681 | 2 | 2-2-2-2-2-2-2 | Clinical isolate | USA | Washington, DC | 2003 | |
| 41) | OIFC111 | AMFY00000000 | 40.8 | HQD | 44 | 3732 | 3,988,061 | 49 | 3-3-6-2-3-1-5 | Perineum | USA | Washington, DC | 2003 | |
| 42) | Naval-78 | AMFZ00000000 | 39.9 | HQD | 112 | 3950 | 4,053,379 | 2 | 2-2-2-2-2-2-2 | Wound | USA | Bethesda, MD | 2006 | [ |
| 43) | AA-014 | AMGA00000000 | 39.4 | HQD | 61 | 3618 | 3,857,932 | 158 | 41-42-13-1-5-4-14 | Wound | Iraq | Al Anbar | 2008 | |
| 44) | MRSN 3405 | JPIA00000000 | 38.3 | IHQD | 64 | 3958 | 4,082,715 | 94 | 1-2-2-1-5-1-1 | Wound | USA | Washington, DC | 2011 | [ |
| 45) | MRSN 3527 | JPHZ00000000 | 38.7 | IHQD | 46 | 4101 | 4,206,186 | 81 | 1-1-1-1-5-1-2 | Wound | USA | Washington, DC | 2011 | [ |
| 46) | MRSN 3942 | JPHY00000000 | 38.4 | IHQD | 69 | 3849 | 3.975,719 | 94 | 1-2-2-1-5-1-1 | Wound | USA | Washington, DC | 2011 | [ |
| 47) | MRSN 4106 | JPHX00000000 | 38.6 | IHQD | 62 | 3824 | 3,952,684 | 94 | 1-2-2-1-5-1-1 | Wound | USA | Washington, DC | 2011 | [ |
| 48) | MRSN 58 | JPHW00000000 | 39.8 | IHQD | 40 | 3866 | 3,974,176 | 1 | 1-1-1-1-5-1-1 | Wound | USA | Washington, DC | 2010 | [ |
| 49) | MRSN 7339‡ | JPHV00000000 | 39.3 | IHQD | 34 | 3787 | 3,955,466 | 1 | 1-1-1-1-5-1-1 | Wound | USA | Washington, DC | 2004 | |
| 50) | MRSN 7341‡ | JPIB00000000 | 39.4 | IHQD | 52 | 3766 | 3,911,280 | 2 | 2-2-2-2-2-2-2 | Respiratory | USA | Washington, DC | 2004 |
†Improved high-quality draft (IHQD); high-quality draft (HQD)
§ cpn60:fusA:gltA:pyrG:recA:rplB:rpoB
*Sample isolated from a soldier evacuated via Landstuhl Regional Medical Center
‡Isolated from the same individual
MLST multilocus sequence typing, NA not available, NI not identified
Fig. 1Analysis of the A. baumannii pan-genome. The distribution of protein cluster sizes generated from the comparison of 249 A. baumannii genomes using PanOCT [35] indicates the number of singleton and core genes (a). The pan-genome size (left panel) and the number of novel genes discovered with the addition of each new genome (right panel) were estimated for all 249 genomes (b) and a set of 100 representative genomes identified by hierarchical clustering of all 249 genomes (c) using a pan-genome model based on the original Tettelin et al. model [42]. Purple circles are the median of each distribution (gray circles). Power law (red lines) and exponential (blue lines) regressions were plotted to determine α (open/closed status) and tg(θ), the average extrapolated number of strain-specific/novel genes, respectively [41]
Fig. 2Pan-chromosome and fGIs. The core gene cluster (cGC), flexible gene cluster (fGC) and flexible genomic region (fGR) locations of the A. baumannii pan-genome (a) were computed from PanOCT output and are illustrated as a circle where each concentric circle is numbered from the outermost to the innermost circle (b). fGR locations are depicted in circles 1 (>20,000 bp), 2 (10,001–20,000 bp), and 3 (1000–10,000 bp) on a core backbone of genes in circles 4 (positive strand) and 5 (negative strand). Refer to the key for details on color representations, circle number and bar height. Key fGRs are noted by black numbering and letters K (K-antigen), N (Novel), and O (O-antigen) as in Table 2. Gray numbers indicate positions on the pan-chromosome in megabase pairs. Predicted functions are noted in gray words and the following abbreviations: RI resistance island, GI genomic island, ɸ phage. Genes associated with RI insertions are labeled in gray and indicated by a black line. The frequency of individual fGIs within six size class bins was also determined (c)
Analysis of select fGIs from the A. baumannii pan-chromosome
| fGR | Functional categories | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Region number+ | End5 | End3 | Span (bp) | Number of fGIs | RI | GI | Phage | Metabolic | House-keeping | Extracellular polysaccharide | Description of largest fGI-encoded functions£ | pAICU ¶ | Flanking† core ACICU loci | fGR id‡ | Largest fGI assemblies§ |
| K | 68497 | 82812 | 14316 | 17 | X | K-antigen | 1 | 00074/00087 | CL_INS_4 | 105 | |||||
| N | 152392 | 155346 | 2955 | 3 | X | Novel; acetyltransferase, fragment of composite IS26 transposon | - | 00139 (acylCS)/00147 | CL_INS_12 | 791* | |||||
| 1 | 243163 | 350187 | 107025 | 38 | X |
| 3 | 00219/00242 | CL_INS_20 | 58* | |||||
| 2 | 702940 | 747393 | 44454 | 7 | X | Copper/heavy metal resistance | - | 00567/00568 | CL_INS_49 | 16 | |||||
| 3 | 906910 | 938373 | 31464 | 9 | X | Phage 1 in ACICU, but no core phage genes | 6 | 00684/00702 | CL_INS_65 | 64 | |||||
| 4 | 1103071 | 1189920 | 86850 | 62 | X | Toxin/anti-toxin system, large terminase, methylase | - | 00861/00869 | CL_INS_74 | 9 | |||||
| 5 | 1401709 | 1425417 | 23709 | 43 | X | phage protein F-like | - | 01048/01056 | CL_INS_93 | 29 | |||||
| 6 | 1425814 | 1449657 | 23844 | 31 | X | Arc-like protein, lysozyme | CL_INS_94 | 76 | |||||||
| 7 | 1472644 | 1510578 | 37935 | 16 | X | Major capsid, prohead protease, portal, large and small terminase, head-tail adaptor, tail protein, lysozyme, antitermination protein Q, integrase | CL_INS_97 | 14 | |||||||
| 8 | 1561693 | 1595358 | 33666 | 11 | X | Zeta toxin, phage/plasmid-like protein, recombinase | - | 01106/01110 | CL_INS_101 | 52 | |||||
| 9 | 1603966 | 1639890 | 35925 | 2 | X |
| - | 01115/01116 | CL_INS_104 | 38, 260* | |||||
| 10 | 1666240 | 1704336 | 38097 | 7 | X | Aldehyde dehydrogenase, vanillin dehydrogenase, porins, transporters | - | 01136 ( | CL_INS_107 | 28 | |||||
| 11 | 1818532 | 1852125 | 33594 | 12 | X | Lysis protein, tail, tail assembly, tape measure | - | 01222/01224 | CL_INS_120 | 50 | |||||
| 12 | 1928539 | 1956234 | 27696 | 2 | X |
| - | 01256/01257 | CL_INS_128 | 38 | |||||
| 13 | 2402650 | 2440626 | 37977 | 32 | X | Major capsid, prohead protease, portal, large and small terminase, head-tail adaptor, tail protein, lysozyme, antitermination protein Q, integrase | - | 01626/01627 | CL_INS_164 | 14 | |||||
| 14 | 2664622 | 2705871 | 41250 | 11 | X | Inovirus-like; zonula occludens toxin, coat protein B, replication protein | - | 01813/01815 | CL_INS_180 | 110 | |||||
| 15 | 2716186 | 2754267 | 38082 | 6 | X | X |
| - | 01824/01827 | CL_INS_182 | 33 | ||||
| 16 | 2802271 | 2828589 | 26319 | 15 | X | Phage-associated protein, phage protein F-like, site-specific recombinase | - | 01849/01864 | CL_INS_187 | 40 | |||||
| 17 | 2850997 | 2872608 | 21612 | 2 | X | Oxidoreductase, aldehyde dehydrogenase | - | 01886/01887 | CL_INS_190 | 62 | |||||
| 18 | 2874184 | 2899845 | 25662 | 2 | X | X | tRNA ligase, aldehyde dehydrogenases, Homoprotocatechuate/hydroxyphenylacetate degradation, transporter | - | 01887/01888 | CL_INS_191 | 37 | ||||
| 19 | 2990911 | 3011439 | 20529 | 4 | X | Medium chain fatty acid ligase, transporter, oxidoreductase | - | 01936/01949 | CL_INS_199 | 121 | |||||
| 20 | 3143872 | 3176853 | 32982 | 7 | X | Mu-like; Gam-like protein, terminase, methylase, Mu protein F-like, Mu-like major head, tail sheath-like, Mu Gp45, baseplate J-like | - | 02064/02066 | CL_INS_211 | 15 | |||||
| 21 | 3250042 | 3277383 | 27342 | 12 | X | lysozyme, baseplate, phage protein F-like, phage-associated protein | - | 02139/02236 | CL_INS_216 | 25 | |||||
| 22 | 3465244 | 3487854 | 22611 | 3 | X | Novel 7.8 kb region; salicylate monooxygenase | - | 02398/02399 (acetylT) | CL_INS_237 | 338* | |||||
| 23 | 3569029 | 3597828 | 28800 | 6 | X | Phage | - | 02457/02470 | CL_INS_246 | 19 | |||||
| 24 | 3790117 | 3828819 | 38703 | 12 | X | Rubredoxin, MFS transporter, prevent host death, aldehyde dehydrogenase, methylmalonate-semialdehyde dehydrogenase | 29 | 02595/02624 | CL_INS_259 | 35 | |||||
| 25 | 4223758 | 4247211 | 23454 | 6 | X | Integrase, CII, large and small terminase, portal, prohead protease, major capsid, head-tail connector, head-tail joining, tail | - | 03014/03015 | CL_INS_287 | 59 | |||||
| O | 4387696 | 4395870 | 8175 | 5 | X | O-antigen | - | 03146/03149 | CL_INS_297 | 168 | |||||
| 26 | 4420246 | 4450038 | 29793 | 6 | X | P2-like; integrase, tape measure, tail proteins, baseplate J-like, lysozyme, baseplate assembly, large and small terminase, major capsid, capsid scaffolding protein, portal | - | 03157/03161 | CL_INS_299 | 17 | |||||
| 27 | 4818799 | 4844895 | 26097 | 2 | X | X | Novel; | - | 03502/03503 | CL_INS_334 | 39 | ||||
| 28 | 4960555 | 4989495 | 28941 | 5 | X |
| - | 03594/03595 | CL_INS_346 | 148 | |||||
+Cross reference with Fig. 4B
£Only functions from select fGIs are listed. Other elements and functions may be encoded within selected fGRs
†Not all fGIs are present in ACICU
¶Largest fGI in fGR similar in composition to the “alien islands” reported by Iacono et al. [38]
‡Cross reference Additional files 5 and 21
§Cross reference Additional files 18 and 21
*Not largest fGI in region
Fig. 4Virulence and fitness factors displaying variable gene content based on centroid-to-ortholog BSR. Specific genomic regions involved in the assembly of type I pili, siderophore production and efflux were highly variable and showed specific gain or loss of entire gene clusters in isolates analyzed. In the BSR-based heat map, the presence, absence, and low similarity of a protein ortholog compared with its centroid is shown in yellow (BSR = 1, presence), blue (BSR = 0, absence), and gray (low similarity or truncated), respectively. The year of collection is shown above strain names. Isolates collected prior to year 2000 are indicated with an asterisk. In summary, gene gain/loss events involved in virulence and survival were detected in decades-old isolates and appeared to have reemerged among recent isolates. The list of virulence genes analyzed and the full size version of the BSR-derived heat map are provided in Additional files 17 and 19, respectively
Fig. 3Clone-type specific RI signatures and RI insertion frequencies over time. a–c Genomic locations of RI signatures specific to clonal complexes (CCs) 1–3 and ST 25. In CC1 isolates, RI insertions are detected in the comM and/or pho loci (a). In CC2 isolates, RI insertions are found in the comM locus, and in addition the astA, or acetylT locus. A novel RI insertion (composite IS26) was identified in CC3 isolates at the acyl-CoA synthase (acylCS) locus (b). Gene annotation of the composite IS26 RI is shown to the right. Drug resistance genes (green); immediate flanking genes acylCS and a transporter protein (dark orange). A novel GI was identified in ST 25 isolates at the acetylT locus (c). Gene annotation of the 7.8 kb GI is shown to the right. Salicylate monooxygenase (blue); immediate flanking genes acetylT and mdtL (dark orange). A cumulative frequency graph showing the number of RI-positive isolates carrying single, double, or triple RI insertions collected between 1950 and 2011 (d). Isolates that represent the first occurrence of a given RI signature are labeled on the graph (numbered 1–9)
Diversity of virulence gene content across A. baumannii isolates
| Gene clusters | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Isolates | Genome category | Source | Year | ST | Allele summary | Country | 1 | 2 | 3 | 4 |
|
| ||||||||||
|
| Global | Urinary | 2001 | 1 | 1-1-1-1-5-1-1 | France | + | + | + | |
|
| Global | Internal | 2005 | 2 | 2-2-2-2-2-2-2 | Italy | + | + | - | |
|
| Global | Miscellaneous | 2000 | 17 | 3-29-30-1-9-1-4 | France | - | - | - | |
|
| Global | Respiratory | 1994 | 10 | 1-3-2-1-4-4-4 | Czech Republic | - | + | + | |
|
| WRAIR | Miscellaneous | 2003 | 10 | 1-3-2-1-4-4-4 | Germany | - | + | + | |
|
| Global | Blood | 2006 | 2 | 2-2-2-2-2-2-2 | China | -1 | + | - | |
| UH clade B2 | US hospital | Respiratory3 | 2007 | 2 | 2-2-2-2-2-2-2 | USA | -1 | + | - | |
|
| Global | Respiratory | 1992 | 34 | 8-1-14-3-12-1-13 | Czech Republic | + | - | + | |
|
| Global | Unknown | 1982 | 2 | 2-2-2-2-2-2-2 | Netherlands | + | + | -4 | |
|
| Global | Miscellaneous | Before 2011 | 2 | 2-2-2-2-2-2-2 | China | + | + | -4 | |
|
| WRAIR | Wound | 2003 | 25 | 3-3-2-4-7-2-4 | USA | + | + | -4 | |
|
| ||||||||||
|
| Global | Urinary | 2001 | 1 | 1-1-1-1-5-1-1 | France | + | - | + | - |
|
| Global | Internal | 2005 | 2 | 2-2-2-2-2-2-2 | Italy | + | - | + | - |
|
| Global | Miscellaneous | 2000 | 17 | 3-29-30-1-9-1-4 | France | - | - | - | - |
|
| Global | Unknown | 1993 | 9 | 3-1-5-3-6-1-3 | Czech Republic | - | - | + | - |
|
| Global | Blood | 1996 | 39 | 10-4-3-2-13-1-2 | Czech Republic | - | - | + | - |
|
| WRAIR | Respiratory | 2003 | 412 | 1-52-2-2-67-4-5 | USA | - | - | + | - |
|
| WRAIR | Miscellaneous | 2003 | Novel | 1-75-2-2-67-1-2 | USA | - | - | + | - |
|
| WRAIR | Blood | 2006 | 410 | 3-1-2-3-6-1-16 | USA | - | - | + | - |
|
| WRAIR | Skin | 2008 | 412 | 1-52-2-2-67-4-5 | Iraq | - | - | + | - |
|
| Global | Miscellaneous | 1951 | 437 | 3-2-2-2-30-4-28 | NA | + | +6 | + | - |
| 6013113 | Global | Skin | 2007 | 81 | 1-1-1-1-5-1-2 | England | + | + | + | - |
| 6013150 | Global | Skin | 2007 | 81 | 1-1-1-1-5-1-2 | England | + | + | + | - |
|
| MRSN | Wound | 2011 | 81 | 1-1-1-1-5-1-2 | USA | + | + | + | - |
|
| MRSN | Wound | 2011 | 94 | 1-2-2-1-5-1-1 | USA | + | + | + | - |
|
| MRSN | Wound | 2011 | 94 | 1-2-2-1-5-1-1 | USA | + | + | + | - |
|
| MRSN | Wound | 2011 | 94 | 1-2-2-1-5-1-1 | USA | + | + | + | - |
|
| WRAIR | Skin | 2008 | 410 | 20-26-26-14-26-16-23 | Iraq | - | - | - | +8 |
|
| ||||||||||
|
| Global | Urinary | 2001 | 1 | 1-1-1-1-5-1-1 | France | + | + | + | |
|
| Global | Internal | 2005 | 2 | 2-2-2-2-2-2-2 | Italy | + | + | + | |
|
| Global | Miscellaneous | 2000 | 17 | 3-29-30-1-9-1-4 | France | - | + | + | |
|
| Global | Respiratory | 1992 | 34 | 8-1-14-3-12-1-13 | Czech Republic | - | + | + | |
|
| Global | Blood | 1993 | 37 | 3-2-2-2-7-1-2 | Czech Republic | - | + | + | |
|
| Global | Respiratory | 1994 | 12 | 3-5-7-1-7-2-6 | Czech Republic | - | + | + | |
|
| Global | Blood | 1996 | 39 | 10-4-3-2-13-1-2 | Czech Republic | - | + | + | |
|
| WRAIR | Miscellaneous | 2003 | Novel | 1-75-2-2-67-1-2 | USA | - | + | + | |
|
| WRAIR | Miscellaneous | 2003 | 49 | 3-3-6-2-3-1-5 | USA | - | + | + | |
| AB900 | WRAIR | Skin | 2003 | 49 | 3-3-6-2-3-1-5 | USA | - | + | + | |
| AB_TG27343 | Global | Wound | 2005 | 422 | 26-72-2-2-29-4-5 | USA | - | + | + | |
| AB_1536-8 | Global | Unknown | 2006 | 413 | 1-3-2-2-5-8-12 | USA | - | + | + | |
| AB_1583-8 | Global | Unknown | 2006 | 422 | 26-72-2-2-29-4-5 | USA | - | + | + | |
|
| WRAIR | Wound | 2006 | 405 | 5-3-16-4-29-1-60 | USA | - | + | + | |
| ZWS1122 | Global | Blood | 2011 | 2 | 2-2-2-2-2-2-2 | China | - | + | + | |
| ZWS1219 | Global | Blood | 2011 | 2 | 2-2-2-2-2-2-2 | China | - | + | + | |
|
| Global | Miscellaneous | 5/2007–4/2008 | 23 | 1-3-10-1-4-4-4 | China | - | + | + | |
Isolate name: finished genomes (bold), pre-2000 isolates (underline), sequenced in this study (italics with asterisk)
Specific gain or loss of gene clusters with respect to majority of isolates analyzed and reference genomes AYE, ACICU, SDF shown as “+” and “-” signs, respectively
(1) A 42 kb deletion was detected in ST2 strain MDR-ZJ06 and the UH clade B isolates, in contrast to the 17 kb deletion observed in ST10 strains NIPH 335 and OIFC098
(2) Nine UH clade B isolates carry a deletion of the type I pili csu gene cluster [40]
(3) Six out of nine UH clade B isolates which showed a loss of the type I pili csu gene cluster are of respiratory origin
(4) Loss of type I pili cluster 3 was detected in 133 isolates, including ST2, ST25, ST79, ST113, and ST215. Only three isolates are shown. Similar gene loss was not detected in ST1 or ST3 isolates
(5) Two isolates (NIPH 410, OIFC047) had a dual loss of siderophore cluster 1 and efflux cluster 1 (AdeABC)
(6) Insertion of siderophore cluster 2 was detected at 3 Mb in ATCC 17978, which differed from the location identified in ST81 and ST94 isolates at 3.8 Mb (coordinates based on ACICU genome)
(7) WC-487 is a non-baumannii Acinetobacter sp. isolate
(8) Siderophore cluster 4 was also detected in A. baumannii 8399 [78, 80]
ATCC American Type Culture Collection, NA not available, WRAIR Walter Reed Army Institute of Research
Fig. 5Loss of pili cluster 1 (csu gene cluster) and gain of siderophore cluster 2 in specific isolates. a Two types of deletion were observed which led to a complete loss of the type I pilus csuAB-E gene cluster. A novel 17 kb deletion was detected in NIPH 335 and OIFC098, whereas a previously reported 42 kb deletion was found in MDR-ZJ06 and nine UH clade B isolates (e.g., UH6207). b Siderophore cluster 2 was detected only in a small subset of isolates across all 249 analyzed. Two apparently independent molecular events were observed among the siderophore cluster 2-positive isolates. In decades-old isolate ATCC 17978, insertion of the gene cluster was detected at a genomic position corresponding to 3.0 Mbp of the ACICU reference genome. c In the remaining siderophore cluster 2-positive modern isolates (e.g., MRSN 3405), insertion was detected at a different location, which corresponds to 3.8 Mbp of the ACICU reference genome. Since ATCC 17978 was isolated in 1951 while other isolates were isolated more recently between 2007 and 2011, the acquiring of siderophore cluster 2 among modern isolates could be an example of the reemergence of a survival mechanism of A. baumannii. The functional significance of siderophore cluster 2 is yet to be determined. Key: pairwise nucleotide identity shown in red to blue (100 % identity) color scale; contig breaks (pink vertical bars); open reading-frames (thick arrows); type I pilus cluster 1 and siderophore cluster 2 genes (green); deleted genes (gray scale); genes bordering insertions/deletions (dark orange and brown); other flanking genes (orange); other genes (light brown)